Literature DB >> 10180748

The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data.

A Desgagné1, A M Castilloux, J F Angers, J LeLorier.   

Abstract

In pharmacoeconomics, the comparison of the costs of 2 different drugs used for the same treatment is of great interest. The problem is especially challenging when the drugs are likely to produce costly adverse effects in a small number of patients, which is often the case. The data are then skewed and traditional statistical methods to analyse the difference in the mean costs produced by 2 treatments may be inappropriate. The bootstrap method is presented as an alternative approach. A pharmacoeconomic cost-analysis example is presented and used throughout this article.

Entities:  

Mesh:

Year:  1998        PMID: 10180748     DOI: 10.2165/00019053-199813050-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  3 in total

Review 1.  Statistical analysis in pharmacoeconomic studies. A review of current issues and standards.

Authors:  D Coyle
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

2.  Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

Authors:  M A Chaudhary; S C Stearns
Journal:  Stat Med       Date:  1996-07-15       Impact factor: 2.373

3.  Methods for comparison of cost data.

Authors:  X H Zhou; C A Melfi; S L Hui
Journal:  Ann Intern Med       Date:  1997-10-15       Impact factor: 25.391

  3 in total
  43 in total

Review 1.  How should cost data in pragmatic randomised trials be analysed?

Authors:  S G Thompson; J A Barber
Journal:  BMJ       Date:  2000-04-29

2.  Use of healthcare services by patients treated with risperidone versus conventional antipsychotic agents.

Authors:  Frank Gianfrancesco; Michael B Durkin; Ramy Mahmoud; Ruey-Hua Wang
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Methods for claims-based pharmacoeconomic studies in psychosis.

Authors:  Frank Gianfrancesco; Ruey-Hua Wang; Ramy Mahmoud; Richard White
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 4.  Economic evaluations: a new avenue of outcome assessment in spinal disorders.

Authors:  Nicole van der Roer; Norbert Boos; Maurits W van Tulder
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

5.  Laparoscopic versus open colorectal surgery: cost-benefit analysis in a single-center randomized trial.

Authors:  Marco Braga; Andrea Vignali; Walter Zuliani; Matteo Frasson; Clelia Di Serio; Valerio Di Carlo
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

6.  Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.

Authors:  Michael Grabner; Eberechukwu Onukwugha; Rahul Jain; C Daniel Mullins
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

7.  An economic evaluation of rt-PA locking solution in dialysis catheters.

Authors:  Braden J Manns; Nairne Scott-Douglas; Marcello Tonelli; Pietro Ravani; Martine LeBlanc; Marc Dorval; Rachel Holden; Louise Moist; Charmaine Lok; Deborah Zimmerman; Flora Au; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

8.  A pharmacy-based health promotion programme in hypertension: cost-benefit analysis.

Authors:  Isabelle Côté; Jean-Pierre Grégoire; Jocelyne Moisan; Isabelle Chabot; Guy Lacroix
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 9.  A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder.

Authors:  Ifigeneia Mavranezouli; Joran Lokkerbol
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

10.  Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery.

Authors:  Joost A van Hilten; Leo M G van de Watering; J Hajo van Bockel; Cornelis J H van de Velde; Job Kievit; Ronald Brand; Wilbert B van den Hout; Robert H Geelkerken; Rudi M H Roumen; Ronald M J Wesselink; Ankie W M M Koopman-van Gemert; Jan Koning; Anneke Brand
Journal:  BMJ       Date:  2004-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.